Strategic Overview

Biopromic develops Biopromic TB LAM, a urine-based test for TB diagnosis.

Innovation Portfolio

Biopromic TB LAM
Category: DIAGNOSIS Stage: Late Stage

Lateral flow immunoassay for urinary LAM detection with enhanced specificity. Designed for HIV-associated TB screening in primary care settings.

Urine-LAM Urine

Key Milestones

Biopromic TB LAM urine test
63% sensitivity, 93% specificity
Primary-level capability
Late-stage development